ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Issues Interim Guidelines For Research Using fetal Tissue

March 26, 1993

In Brief: Resolution wasn’t Strong Enough, Reizen Though; Two More chemicals reported Out of Bioassay

June 3, 1977

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003